Yıl: 2021 Cilt: 63 Sayı: 4 Sayfa Aralığı: 292 - 296 Metin Dili: İngilizce DOI: 10.4274/gulhane.galenos.2021.1658 İndeks Tarihi: 08-06-2022

The comparison of SUVmax values in 18 F-FDG PET/CT according to cell type, stage, lymph node involvement and metastasis in lung cancers

Öz:
Aims: 18 F-fluoro-2-deoxy-D-glucose positron emission tomography/computerized tomography (PET/CT) provides metabolic information in addition to anatomic extension. This study aimed to compare the primary tumor maximum standardized uptake values (SUVmax ) on PET/CT according to the histopathological type, stage, nodal involvement, and the metastasis of lung cancers. Methods: In this retrospective study, PET/CTs of the patients with lung cancer were examined. Staging of the cancer was performed according to the eighth (8 th ) edition of the tumor, node and metastasis (TNM) classification system. SUVmax values were recorded and compared. Results: Two hundred thirty-three patients with lung cancer (78.5% male, mean age: 67.0±9.6 years, range: 47-91 years) were analyzed. The SUVmax value of squamous cell carcinoma (SCC) (15.2±7.6) was higher than the SUVmax values of adenocarcinoma (AC) and small cell lung carcinoma (SCLC) (10.9±5.6 and 12.2±5.5, respectively, p<0.001). SUVmax values were not different between the stages of AC, SCC and SCLC (p=0.285, p=0.377 and p=0.061, respectively). SUVmax values were similar between nodal involvements (p=0.490, p=0.645 and p=0.114 for AC, SCC, and SCLC, respectively). There was no difference in SUVmax values of lung cancers with and without metastasis (p=0.496, p=0.209, and p=0.544 for AC, SCC, and SCLC, respectively). Conclusions: The SUVmax value of SCC was highest among lung cancers. There was no significant difference between the SUVmax value of the primary tumor on PET/CT and the TNM stages of the tumor.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Bade BC, Dela Cruz CS. Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clin Chest Med. 2020;41:1-24.
  • 2. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2016, National Cancer Institute. Bethesda, MD. Last Accessed Date: 01.04.2019. Available from: https://seer.cancer.gov/csr/1975_2016/
  • 3. Yıldız ÖÖ, Çelik İA. A different perspective on the correlation between histopathological type and PET-CT SUVmax in non-small cell lung cancer: A retrospective cohort study. J Surg Med. 2019;3:357-360.
  • 4. Verma S, Chan J, Chew C, Schultz C. PET-SUV Max and Upstaging of Lung Cancer. Heart Lung Circ. 2019;28:436- 442.
  • 5. Warburg O. Warburg report on the metabolism of tumors. J Chem Educat. 1930;7:179.
  • 6. Dooms C, van Baardwijk A, Verbeken E, et al. Association between 18F-fluoro-2-deoxy-D-glucose uptake values and tumor vitality: prognostic value of positron emission tomography in early-stage non-small cell lung cancer. J Thorac Oncol. 2009;4:822-828.
  • 7. De Leyn P, Dooms C, Kuzdzal J, et al. Preoperative mediastinal lymph node staging for non-small cell lung cancer: 2014 update of the 2007 ESTS guidelines. Transl Lung Cancer Res. 2014;3:225-233.
  • 8. Shepherd FA, Crowley J, Van Houtte P, et al. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol. 2007;2:1067-1077.
  • 9. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy- D-glucose: variations with body weight and a method for correction. Radiology. 1993;189:847-850.
  • 10. Zhu SH, Zhang Y, Yu YH, et al. FDG PET-CT in non-small cell lung cancer: relationship between primary tumor FDG uptake and extensional or metastatic potential. Asian Pac J Cancer Prev. 2013;14:2925-2929.
  • 11. Iwano S, Ito S, Tsuchiya K, Kato K, Naganawa S. What causes false-negative PET findings for solid-type lung cancer? Lung Cancer. 2013;79:132-136 . 12. Lu P, Yu L, Li Y, Sun Y. A correlation study between maximum standardized uptake values and pathology and clinical staging in nonsmall cell lung cancer. Nucl Med Commun. 2010;31:646-651.
  • 13. Lim W, Ridge CA, Nicholson AG, Mirsadraee S. The 8th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications. Quant Imaging Med Surg. 2018;8:709-718.
  • 14. El-Sherief AH, Lau CT, Wu CC, Drake RL, Abbott GF, Rice TW. International association for the study of lung cancer (IASLC) lymph node map: radiologic review with CT illustration. Radiographics. 2014;34:1680-1691.
  • 15. Said MA, Musarudin M, Zulkaffli NF. The quantification of PET-CT radiotracers to determine minimal scan time using quadratic formulation. Ann Nucl Med. 2020;34:884-891.
  • 16. Sahiner I, Atasever T, Akdemir UO, Ozturk C, Memis L. Relationship between primary lesion metabolic parameters and clinical stage in lung cancer. Rev Esp Med Nucl Imagen Mol. 2013;32:357-363.
  • 17. Berghmans T, Dusart M, Paesmans M, et al. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG- PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta- analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol. 2008;3:6-12.
  • 18. Nambu A, Kato S, Sato Y, et al. Relationship between maximum standardized uptake value (SUVmetax) of lung cancer and lymph node metastasis on FDG-PET. Ann Nucl Med. 2009;23:269-275.
  • 19. Al-Sarraf N, Gately K, Lucey J, et al. Clinical implication and prognostic significance of standardised uptake value of primary non-small cell lung cancer on positron emission tomography: analysis of 176 cases. Eur J Cardiothorac Surg. 2008;34:892-897.
  • 20. Billé A, Pelosi E, Skanjeti A, et al. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Eur J Cardiothorac Surg. 2009;36:440-445.
  • 21. Ambrosini V, Nicolini S, Caroli P, et al. PET/CT imaging in different types of lung cancer: an overview. Eur J Radiol. 2012;81:988-1001.
  • 22. Li M, Wu N, Zheng R, et al. Primary tumor PET/CT [18 F] FDG uptake is an independent predictive factor for regional lymph node metastasis in patients with non-small cell lung cancer. Cancer Imaging. 2013;12:566-572.
  • 23. Li M, Liu N, Hu M, et al. Relationship between primary tumor fluorodeoxyglucose uptake and nodal or distant metastases at presentation in T1 stage non-small cell lung cancer. Lung Cancer. 2009;63:383-386.
  • 24. Cerfolio RJ, Bryant AS, Ohja B, Bartolucci AA. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg. 2005;130:151-159.
  • 25. Obara P, Pu Y. Prognostic value of metabolic tumor burden in lung cancer. Chin J Cancer Res. 2013;25:615-622.
APA Caliskan T, Canoğlu K, ISIK E (2021). The comparison of SUVmax values in 18 F-FDG PET/CT according to cell type, stage, lymph node involvement and metastasis in lung cancers. , 292 - 296. 10.4274/gulhane.galenos.2021.1658
Chicago Caliskan Tayfun,Canoğlu Kadir,ISIK EMINE GOKNUR The comparison of SUVmax values in 18 F-FDG PET/CT according to cell type, stage, lymph node involvement and metastasis in lung cancers. (2021): 292 - 296. 10.4274/gulhane.galenos.2021.1658
MLA Caliskan Tayfun,Canoğlu Kadir,ISIK EMINE GOKNUR The comparison of SUVmax values in 18 F-FDG PET/CT according to cell type, stage, lymph node involvement and metastasis in lung cancers. , 2021, ss.292 - 296. 10.4274/gulhane.galenos.2021.1658
AMA Caliskan T,Canoğlu K,ISIK E The comparison of SUVmax values in 18 F-FDG PET/CT according to cell type, stage, lymph node involvement and metastasis in lung cancers. . 2021; 292 - 296. 10.4274/gulhane.galenos.2021.1658
Vancouver Caliskan T,Canoğlu K,ISIK E The comparison of SUVmax values in 18 F-FDG PET/CT according to cell type, stage, lymph node involvement and metastasis in lung cancers. . 2021; 292 - 296. 10.4274/gulhane.galenos.2021.1658
IEEE Caliskan T,Canoğlu K,ISIK E "The comparison of SUVmax values in 18 F-FDG PET/CT according to cell type, stage, lymph node involvement and metastasis in lung cancers." , ss.292 - 296, 2021. 10.4274/gulhane.galenos.2021.1658
ISNAD Caliskan, Tayfun vd. "The comparison of SUVmax values in 18 F-FDG PET/CT according to cell type, stage, lymph node involvement and metastasis in lung cancers". (2021), 292-296. https://doi.org/10.4274/gulhane.galenos.2021.1658
APA Caliskan T, Canoğlu K, ISIK E (2021). The comparison of SUVmax values in 18 F-FDG PET/CT according to cell type, stage, lymph node involvement and metastasis in lung cancers. Gülhane Tıp Dergisi, 63(4), 292 - 296. 10.4274/gulhane.galenos.2021.1658
Chicago Caliskan Tayfun,Canoğlu Kadir,ISIK EMINE GOKNUR The comparison of SUVmax values in 18 F-FDG PET/CT according to cell type, stage, lymph node involvement and metastasis in lung cancers. Gülhane Tıp Dergisi 63, no.4 (2021): 292 - 296. 10.4274/gulhane.galenos.2021.1658
MLA Caliskan Tayfun,Canoğlu Kadir,ISIK EMINE GOKNUR The comparison of SUVmax values in 18 F-FDG PET/CT according to cell type, stage, lymph node involvement and metastasis in lung cancers. Gülhane Tıp Dergisi, vol.63, no.4, 2021, ss.292 - 296. 10.4274/gulhane.galenos.2021.1658
AMA Caliskan T,Canoğlu K,ISIK E The comparison of SUVmax values in 18 F-FDG PET/CT according to cell type, stage, lymph node involvement and metastasis in lung cancers. Gülhane Tıp Dergisi. 2021; 63(4): 292 - 296. 10.4274/gulhane.galenos.2021.1658
Vancouver Caliskan T,Canoğlu K,ISIK E The comparison of SUVmax values in 18 F-FDG PET/CT according to cell type, stage, lymph node involvement and metastasis in lung cancers. Gülhane Tıp Dergisi. 2021; 63(4): 292 - 296. 10.4274/gulhane.galenos.2021.1658
IEEE Caliskan T,Canoğlu K,ISIK E "The comparison of SUVmax values in 18 F-FDG PET/CT according to cell type, stage, lymph node involvement and metastasis in lung cancers." Gülhane Tıp Dergisi, 63, ss.292 - 296, 2021. 10.4274/gulhane.galenos.2021.1658
ISNAD Caliskan, Tayfun vd. "The comparison of SUVmax values in 18 F-FDG PET/CT according to cell type, stage, lymph node involvement and metastasis in lung cancers". Gülhane Tıp Dergisi 63/4 (2021), 292-296. https://doi.org/10.4274/gulhane.galenos.2021.1658